Abstract
ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have